跳至主要内容
临床试验/NCT07842133
NCT07842133招募中不适用

The Effect of Progressive Muscle Relaxation Exercises on Fatigue, Dyspnea, and Respiratory Function in Patients With Systemic Sclerosis: A Randomized Controlled Trial

University of Gaziantep1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2026年4月25日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
入组人数
50
试验地点
1
主要终点
Respiratory function measured by forced expiratory volume in 1 second (FEV1) and forced vital capacity (FVC)

研究概览

简要总结

This study aims to evaluate the effects of progressive muscle relaxation exercises on fatigue, dyspnea, and respiratory function in patients with systemic sclerosis. Participants will be assessed before and after the intervention.

详细描述

Systemic sclerosis is a chronic autoimmune connective tissue disease that can affect multiple organs, including the respiratory system. Respiratory involvement may lead to symptoms such as dyspnea and fatigue and may adversely affect respiratory function and quality of life.

Progressive muscle relaxation exercise is a non-pharmacological relaxation technique that involves systematically tensing and relaxing different muscle groups. This technique may reduce physical and psychological tension and may contribute to the management of symptoms such as fatigue and dyspnea.

The purpose of this study is to evaluate the effect of progressive muscle relaxation exercises on fatigue, dyspnea, and respiratory function in patients with systemic sclerosis. Participants will undergo baseline assessments before the intervention. Progressive muscle relaxation exercises will then be administered, followed by post-intervention assessments to determine changes in fatigue, dyspnea, and respiratory function.

The findings of this study may provide evidence regarding the potential use of progressive muscle relaxation exercises as a supportive non-pharmacological intervention for symptom management in patients with systemic sclerosis.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
None

盲法说明

Participants and outcome assessors are blinded to group allocation. The researcher administering the intervention is aware of the group allocation.

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Individuals who meet the study eligibility criteria will be included in the study. Eligible participants will be adults aged 18 years or older, diagnosed with systemic sclerosis, and have adequate physical and cognitive capacity to participate in the study.

排除标准

  • •Individuals who do not meet the inclusion criteria, who are unable to participate in the progressive muscle relaxation exercises due to their physical or cognitive condition, or who withdraw from the study voluntarily will be excluded from the study.

研究组 & 干预措施

Progressive Muscle Relaxation Exercise Group

Experimental

Participants randomly assigned to this group will receive progressive muscle relaxation exercises in addition to standard care.

干预措施: Progressive Muscle Relaxation Exercise (Behavioral)

Control Group

No Intervention

Participants randomly assigned to this group will receive standard care without progressive muscle relaxation exercises.

结局指标

主要结局

Respiratory function measured by forced expiratory volume in 1 second (FEV1) and forced vital capacity (FVC)

时间窗: Baseline and 4 weeks after the intervention

Respiratory function will be assessed using spirometry, including forced expiratory volume in 1 second (FEV1) and forced vital capacity (FVC). Changes in FEV1 and FVC from baseline to post-intervention assessment will be evaluated between the intervention and control groups.

Fatigue severity measured by the FACIT-Fatigue Scale

时间窗: Baseline and 4 weeks after the intervention

Fatigue will be assessed using the Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-Fatigue) Scale. Changes in fatigue scores from baseline to post-intervention assessment will be evaluated between the intervention and control groups.

Dyspnea severity measured by the Dyspnea-12 (D-12) Scale

时间窗: Baseline and 4 weeks after the intervention

Dyspnea will be assessed using the Dyspnea-12 (D-12) Scale. Changes in dyspnea scores from baseline to post-intervention assessment will be evaluated between the intervention and control groups.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Adile Nese

Assistant Professor

University of Gaziantep

研究点 (1)

Loading locations...

相似试验